Heart block - Treatment with chloroquine sulphate or chloroquine phosphate or hydroxychloroquine Factor
Last reviewed for CCPS 18 July 2006.
Investigative Documents
Claimant Report - Treatment with a Chloroquine Drug - Heart Block [CR9260]
Medical Report - Treatment with Chloroquine Sulphate, Chloroquine Phosphate or Hydroxychloroquine - Heart Block [MR9338]
Preliminary questions [35960]
there is some evidence that treatment with daily chloroquine sulphate, chloroquine phosphate or hydroxychloroquine may be a factor in the development of the condition under consideration.36081 the veteran has been treated with daily chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year at some time.
36083 — the veteran has established the causal connection between treatment with daily chloroquine and VEA service for the clinical onset of heart block.
36084 — the veteran has established the causal connection between treatment with daily chloroquine and operational service for the clinical onset of heart block.
or
36085 — the veteran has established the causal connection between treatment with daily chloroquine and eligible service for the clinical onset of heart block.
Clinical onset and operational service [36084]
the veteran was treated with daily chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year before the clinical onset of the condition under consideration. operational service made a material contribution to the veteran's treatment with daily chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year before the clinical onset of the condition under consideration.or
the treatment with daily chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year was materially contributed to by treatment of an illness or injury which is identifiable.36086 the identified illness or injury made a material contribution to the veteran being treated with daily chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year before the clinical onset of heart block.
36088 — the identified illness or injury which made a material contribution to the veteran being treated with daily chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year is causally related to operational service.
Clinical onset and eligible service [36085]
the veteran has been treated with daily chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least two years at some time. the veteran was treated with daily chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least two years before the clinical onset of the condition under consideration. eligible service made a material contribution to the veteran's treatment with daily chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least two years before the clinical onset of the condition under consideration.or
the treatment with daily chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year was materially contributed to by treatment of an illness or injury which is identifiable.36090 the identified illness or injury made a material contribution to the veteran being treated with daily chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least two years.
the identified illness or injury made a material contribution to the veteran being treated with daily chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least two years before the clinical onset of heart block.36089 — the identified illness or injury which made a material contribution to the veteran being treated with daily chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least two years is causally related to eligible service.